Product Program year 2020 Source: CMS Open Payments

Probuphine

Drug Maintenance Treatment of Opioid Dependence

NDC 52440-100-14

Open in the dashboard

General payments

$210,870

384 payments

Research payments

$0

0 payments

Through program year 2020, $210,870 in general payments and $0 in research payments were reported against Probuphine (Maintenance Treatment of Opioid Dependence).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $61,196 157
2019 General $149,674 227

Breakdown

Who paid General payments · program years 2019–2020
  1. Titan Pharmaceuticals, Inc. $210,870 384 payments
Top recipients General payments · program year 2020
  1. Steven Chavoustie Gynecology · Miami, FL $18,600 30% · 5 payments
  2. Kathleen Todd Family Medicine · Mailtand, FL $16,097 26% · 12 payments
  3. Harry Boatwright Obstetrics & Gynecology · Charleston, SC $7,977 13% · 6 payments
  4. Michael Frost Internal Medicine · Ambler, PA $7,570 12% · 4 payments
  5. Matthew Torrington Addiction Medicine · Culver City, CA $4,668 8% · 3 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Gynecology Obstetrics & Gynecology $18,600 30% · 1 practitioner
  2. Family Medicine $17,939 29% · 36 practitioners
  3. Obstetrics & Gynecology $7,977 13% · 1 practitioner
  4. Internal Medicine $7,760 13% · 10 practitioners
  5. Addiction Medicine Family Medicine $5,106 8% · 10 practitioners

The top 5 of 25 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Florida $34,740 57% · 4 recipients
  2. South Carolina $8,318 14% · 11 recipients
  3. Pennsylvania $7,877 13% · 5 recipients
  4. California $6,153 10% · 21 recipients
  5. Michigan $1,957 3% · 9 recipients

The top 5 of 25 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

384 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record